Some kind words about our Summit

“Unrivalled!”

The CMTA’s inaugural CMT Clinical Summit provides an unrivalled opportunity to connect with CMT experts and colleagues from around the world. The CMTA’s Strategy to Accelerate Research (STAR) and global consortium of researchers, clinicians and alliance partners is driving rapid advances in CMT research. This Clinical Summit provides an essential opportunity for all those working with CMT patients to refresh and update their knowledge and practice.

Dr Katherine Forsey
Chief Research Officer, CMTA

“First of its Kind!”

With the goal of expanding our commitment to improving care for all people living with Charcot-Marie-Tooth disease, the CMTA is hosting the first of its kind CMT Clinical Summit. CMT experts will be providing disease education in the areas of neurology, genetics, clinical trials/studies, surgical intervention, PT/OT, breathing-related issues, and social work. It has been a desire of the CMT patient community for years that their general health care professionals learn more about CMT. We are elated to make this type of education a reality.

Laurel Richardson
Director of Community Outreach, CMTA

“Unprecedented!”

Driven by the CMTA’s global leadership in developing Charcot-Marie-Tooth disease modifying treatments and ultimately a cure, CMT understandings are advancing at an explosive rate. The CMTA’s unwavering commitment to improve the lives of everybody living with this rare and complex disease, the first ever CMT Clinical Summit provides an unprecedented opportunity for physicians and practicing clinicians to learn about the latest discoveries of disease cause, to learn about the latest understandings of disease presentation, and to learn about cutting-edge CMT clinical management strategies that have the potential to change the lives of the CMT patients they care for. This is a pioneering event like no other.

Kenneth Raymond
CMTA Advisory Board Member and Patient Advocate